Standout Papers

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomi... 2022 2026 2023 2024122
  1. Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers (2022)
    Caroline Holm Nørgaard, Sarah Friedrich et al. Alzheimer s & Dementia Translational Research & Clinical Interventions

Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
2024 Standout
Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
2024 Standout
1 intermediate paper

Works of Sarah Friedrich being referenced

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
2022 Standout

Author Peers

Author Last Decade Papers Cites
Sarah Friedrich 99 94 34 86 40 658
Christopher Kaiser 82 63 48 48 34 795
Stefan Englert 79 80 18 23 33 683
David C. Hurst 52 72 64 39 33 776
Guido Skipka 85 89 58 28 28 838
Simin Baygani 44 104 36 94 36 605
Allison Meisner 51 65 191 36 33 850
Shuai Chen 107 84 4 20 44 610
Jinzhu Jia 91 44 57 43 63 652
Ji Chen 30 38 84 40 41 613
Antje Jahn‐Eimermacher 133 57 53 9 33 592

All Works

Loading papers...

Rankless by CCL
2026